(Q47223075)

12 January 2018

title

Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion (English)

1 reference

12 January 2018

author name string

Kingma JG Jr

series ordinal

1

1 reference

12 January 2018

Plante S

series ordinal

2

1 reference

12 January 2018

Bogaty P

series ordinal

3

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 December 2000

1 reference

12 January 2018

Journal of the American College of Cardiology

published in

1 reference

12 January 2018

volume

36

1 reference

12 January 2018

issue

7

1 reference

12 January 2018

page(s)

2317-2324

1 reference

12 January 2018

Novel antiplatelet therapies for treatment of patients with ischemic heart disease: inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Monitoring platelet GP IIb/IIIa antagonist therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Therapeutic heparin concentrations augment platelet reactivity: implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximab

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Role of new antiplatelet agents as adjunctive therapies in thrombolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Is the reduction of myocardial infarct size by dietary fish oil the result of altered platelet function?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Myocardial temperature reduction attenuates necrosis after prolonged ischemia in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

SIMPLIFIED TECHNIQUE FOR CHRONIC CATHETERIZATION OF BLOOD VESSELS.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Preconditioning does not attenuate myocardial stunning

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Microvascular sites and mechanisms responsible for reactive hyperemia in the coronary circulation of the beating canine heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

The electronic aggregometer: a novel device for assessing platelet behavior in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Platelet aggregates as markers of platelet activation: characterization of flow cytometric method suitable for clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Augmentation of regional function in nonischemic myocardium during coronary occlusion measured with two-dimensional echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Platelet activation in unstable coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Intracoronary platelet aggregation: pattern of deposition after ischemia, cardioplegia, and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Effects of heparin and its desulfated derivatives on leukocyte-endothelial adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Intravenous and oral antiplatelet/antithrombotic efficacy and specificity of XR300, a novel nonpeptide platelet GPIIb/IIIa antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Reduction in coronary vasodilator reserve following coronary occlusion and reperfusion in anesthetized dog: role of endothelium-derived relaxing factor, myocardial neutrophil infiltration and prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Decreased coronary flow reserve after transient myocardial ischemia in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

Prolonged impairment of coronary vasodilation after reversible ischemia. Evidence for microvascular "stunning".

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901016-0

7 January 2021

10.1016/S0735-1097(00)01016-0

Identifiers

DOI

1 reference

12 January 2018

PubMed ID

11127479

1 reference

12 January 2018